1011 GMT - Ergomed has appointed Michael Spiteri as chief transformation and technology officer and Jonathan Curtain as deputy chief financial officer, both names with strong management capabilities that will support the growth objectives of the pharmaceutical-industry services provider, Davy Research says. Both appointees have considerable background in the operations and business of the company, suggesting the transition into the new roles will be smooth, Davy analysts Colin Grant and Hammad Anwar say in a research note. The appointments are further evidence of Ergomed's strategy of investing in expanding its management and IT capabilities, both considered vital in its next stages, the Irish research firm says. Davy retains its outperform rating on Ergomed's stock. Shares are down 3.2% at 1,437.0 pence. (joseph.hoppe@wsj.com)
Contact: London NewsPlus, Dow Jones Newswires; Dow Jones Newswires; paul.larkins@wsj.com
(END) Dow Jones Newswires
11-17-22 0644ET
